Coherus Biosciences reported $446.78M in Current Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 532.52M 9.7M
Aerie Pharmaceuticals AERI:US $ 311.41M 5.56M
Akebia Therapeutics AKBA:US $ 304.16M 1.48M
ALKERMES ALKS:US 1.05B 31.16M
Alnylam Pharmaceuticals ALNY:US $ 2471.64M 118.04M
Amarin AMRN:US $ 719.12M 53.5M
Amgen AMGN:US $ 19322M 802M
Baxter International BAX:US $ 7882M 291M
Biogen BIIB:US $ 9740.9M 1825M
Biomarin Pharmaceutical BMRN:US $ 2517.6M 123.57M
Bluebird Bio BLUE:US $ 167.46M 87.46M
Bristol Myers Squibb BMY:US $ 30186M 65M
Coherus Biosciences CHRS:US $ 446.78M 65.66M
Eli Lilly And LLY:US $ 17115.2M 150.5M
Endo International Ordinary Shares ENDP:US $ 2199.9M 292.89M
Fujifilm 4901:JP Y 1892758M 168029M
Gilead Sciences GILD:US $ 13705M 1076M
Horizon Pharma HZNP:US $ 3203.09M 255.36M
Ironwood Pharmaceuticals IRWD:US $ 617.83M 92.28M
JAZZ PHA JAZZ:US $ 2590.83M 89.98M
LG Chem 051910:KS 32764.67B 12350.85B
Pacira Pharmaceuticals PCRX:US $ 526.21M 140.81M
Perrigo Ordinary Shares PRGO:US $ 2651.5M 1284M
Ptc Therapeutics PTCT:US $ 694.68M 79.33M
Regeneron Pharmaceuticals REGN:US $ 15529.9M 1223.9M
Revance Therapeutics RVNC:US $ 260.94M 24.38M
Sarepta Therapeutics SRPT:US $ 2469.3M 61.65M
Teva Pharmaceutical TEVA:IT 12.16B 287M
Vertex Pharmaceuticals VRTX:US $ 11503.5M 1142.2M
Xencor XNCR:US $ 585.94M 79.97M
Zoetis ZTS:US $ 6651M 186M